Literature DB >> 23428560

Attitudes and opinion about adverse drug events of women living in a city of south Italy.

Francesco Salvo1, Marco Miroddi, Angela Alibrandi, Fabrizio Calapai, Viviana Cafeo, Ferdinando Mancari, Sebastiano Gangemi, Achille P Caputi, Gioacchino Calapai.   

Abstract

BACKGROUND/AIM: Perception of risk of adverse drug events (ADEs) is different between health and nonhealth professionals, but these differences have not been investigated sufficiently in the general population. Women are more affected by ADEs. With the aim to investigate ADE risk perception in a sample of nonhealth professional women of South Italy, we carried out a phone survey.
METHODS: Phone survey based on a structured questionnaire on educational level, type of work, lifestyle, comorbidity, and medication used of 1,050 inhabitants of the city of Messina (Italy).
RESULTS: 744 responders, divided into an ADE group (n = 162) and a non-ADE group, were analyzed. Most used drugs were nonsteroidal anti-inflammatory drugs (37.0%) and antibiotics (29.6%). Reported disorders related to drug intake were general malaise (25.9%), gastrointestinal complaints (24.1%), and skin reactions (20.4%). Younger age and higher educational level, along with allergic diseases and food intolerances were more frequently reported in the ADE group. Women from the ADE group were better informed about drug risks (p < 0.001).
CONCLUSIONS: Higher risk perception for ADEs in women is associated with higher educational level, food intolerance/allergic diseases, and choice of alternative or complementary medicines. Difference in perception of risk exists within the female population, which can cause overreporting or underreporting of ADEs.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2013        PMID: 23428560     DOI: 10.1159/000346737

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  6 in total

Review 1.  Factors affecting patient reporting of adverse drug reactions: a systematic review.

Authors:  Rania Al Dweik; Dawn Stacey; Dafna Kohen; Sanni Yaya
Journal:  Br J Clin Pharmacol       Date:  2016-11-25       Impact factor: 4.335

2.  The evaluation of adverse drug reactions in Saudi Arabia: A retrospective observational study.

Authors:  Khalidah A Alenzi; Najah S Alanazi; Mohammed Almalki; Homoud Alomrani; Fahad O Alatawi
Journal:  Saudi Pharm J       Date:  2022-03-31       Impact factor: 4.562

3.  Adverse drug reaction profile in Amravati region of India: A pharmacovigilance study.

Authors:  Kishor A Bansod; Mohammed Shakeel Mohammed Bashir; Shilpa S Ingle
Journal:  J Pharm Bioallied Sci       Date:  2020-04-10

4.  Pharmacy study of natural health product adverse reactions (SONAR): a cross-sectional study using active surveillance in community pharmacies to detect adverse events associated with natural health products and assess causality.

Authors:  Candace Necyk; Ross T Tsuyuki; Heather Boon; Brian C Foster; Don Legatt; George Cembrowski; Mano Murty; Joanne Barnes; Theresa L Charrois; John T Arnason; Mark A Ware; Rhonda J Rosychuk; Sunita Vohra
Journal:  BMJ Open       Date:  2014-03-28       Impact factor: 2.692

5.  Prevalence of Drug-Related Emergency Department Visits at a Teaching Hospital in Malaysia.

Authors:  Abubakar Ibrahim Jatau; Myat Moe Thwe Aung; Tuan Hairulnizam Tuan Kamauzaman; Ab Fatah Ab Rahman
Journal:  Drugs Real World Outcomes       Date:  2015-10-23

6.  Adverse drug reactions at adverse drug reaction monitoring center in Raipur: Analysis of spontaneous reports during 1 year.

Authors:  Preeti Singh; Manju Agrawal; Rajesh Hishikar; Usha Joshi; Basant Maheshwari; Ajay Halwai
Journal:  Indian J Pharmacol       Date:  2017 Nov-Dec       Impact factor: 1.200

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.